News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
April, 2025
April 2025
M T W T F S S
 123456
78910111213
14151617181920
21222324252627
282930  
Shushan Hovsepyan: OncoDaily is in Cairo
Shushan Hovsepyan/LinkedIn
Jan 25, 2025, 09:40

Shushan Hovsepyan: OncoDaily is in Cairo

Shushan Hovsepyan, Editor-in-Chief of OncoDaily Medical Journal, shared a post on LinkedIn:

“OncoDaily is in Cairo!

The 17th BGICC has officially started with more than 5,000 participants from across the globe.

Follow OncoDaily for the latest updates and key moments from this incredible event.”

Shushan Hovsepyan: OncoDaily is in Cairo

17th BGICC BGICC 2025 cancer OncoDaily Oncology Shushan Hovsepyan
Special Coverage
Blog
Apr 16, 2025, 19:01
Richard Sullivan: WHO Meeting Reflected on Cancer and IO Drug Pairs
Blog
Apr 16, 2025, 18:50
Join the Third Annual Virtual TAPUR Study Grand Rounds 2025 - ASCO
Blog
Apr 16, 2025, 18:44
The month of the Explore Your Health festival is coming to an end - IARC/WHO
Blog
Apr 16, 2025, 18:38
Why doesn't your body attack the food you eat? - Cancer Research Institute
Blog
Apr 16, 2025, 18:33
Massive Bio has officially received certification from the CNIL
Blog
Apr 16, 2025, 18:17
Peter Pisters: It was wonderful to drop by MD Anderson Cancer Center’s LEADing Leaders/LEADing Institution Training
Blog
Apr 16, 2025, 18:15
MASCC Guidance on Osteoradionecrosis in Patients with Head and Neck Cancer
Blog
Apr 16, 2025, 17:56
Study MSc Transformative Oncology from The University of Manchester online and part-time
Blog
Apr 16, 2025, 17:55
Amol Akhade: Should CDK4/6 inhibitors be standard in early HR+/HER2– breast cancer?
Blog
Apr 16, 2025, 17:46
Dégi László Csaba called for action on QoL in cancer care at EUonQol General Assembly - European Cancer Organisation
Opinion
Apr 16, 2025, 17:39
Is Cancer Hereditary? Myths and Facts about Cancer Genetics
Blog
Apr 16, 2025, 17:37
Are you working on neoadjuvant immunotherapy? - 3P Solution